JBM (Healthcare) Limited (HKG:2161)

Hong Kong · Delayed Price · Currency is HKD

2.290

-0.050 (-2.14%)

Jun 18, 2026, 4:08 PM HKT

-21.58% (1Y)

Market Cap	1.87B -11.2%
Revenue (ttm)	812.98M +12.8%
Net Income	216.39M +32.0%
EPS	0.25 +26.4%
Shares Out	817.30M
PE Ratio	9.30
Forward PE	8.74
Dividend	0.20 (8.52%)
Ex-Dividend Date	n/a

Volume	80,000
Open	2.340
Previous Close	2.340
Day's Range	2.240 - 2.340
52-Week Range	2.230 - 3.430
Beta	0.21
Analysts	Strong Buy
Price Target	3.15 (+37.56%)
Earnings Date	Jun 22, 2026

About JBM (Healthcare)

JBM (Healthcare) Limited, an investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally. It operates through Branded Medicines, Proprietary Chinese Medicines, and Health and Wellness Products segments. The Branded Medicines segment develops, manufactures, and distributes branded medicines with chemical compounds as active ingredients. The Proprietary Chinese Medicines segment develops, manufactures, and distributes... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2020

Employees 412

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 2161

Full Company Profile

Financial Performance

In fiscal year 2025, JBM (Healthcare)'s revenue was 782.29 million, an increase of 20.65% compared to the previous year's 648.42 million. Earnings were 197.26 million, an increase of 51.20%.

Financial Statements